SUMMIT SECURITIES GROUP LLC

Broker-Dealer

Position in TLRY — Tilray Brands, Inc.

CIK 1531593 NEW YORK, NY

Back to TLRY Full portfolio

Position in TLRY

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$26,940

+$1,623 QoQ

Shares Held

6,000

+466.6% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#102

of 233 holders

Holding Since

Mar 2021

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in TLRY Over Time

Shares Held

Position Value (USD)

Derivatives in TLRY

reported options exposure · as of Dec 31, 2021

CallValue

CallShares

PutValue

$42,180

PutShares

600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUMMIT SECURITIES GROUP LLC holds $650,751 across 9 Drug Manufacturers - Specialty & Generic names. TLRY ranks #5 (4.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	7,000	$237,160
2	ELAN	Elanco Animal Health Inc	6,119	$150,588
3	ZTS	Zoetis Inc.	1,599	$114,904
4	LNTH	Lantheus Holdings, Inc.	500	$55,470
5	TLRY	Tilray Brands, Inc. This page	6,000	$26,940
6	PCRX	Pacira BioSciences, Inc.	936	$23,746
7	VTRS	Viatris Inc	1,343	$21,326
8	HROW	Harrow, Inc.	290	$12,316

All Filings in TLRY

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$26,940	6,000	-43.4%	Shares	Sole	2026-08-03
2023-09-30	$25,317	10,593	-81.0%	Shares	Sole	2023-11-13
2021-12-31	$42,180	6,000	+521.8%	Put	Sole	2022-01-18
2021-03-31	$1,266,061	55,700	—	Shares	Sole	2021-04-14
2021-03-31	$13,274	584	—	Call	Sole	2021-04-14
2021-03-31	$21,934	965	—	Put	Sole	2021-04-14
No filing history on record for this holder in this stock.